This content is machine translated Varicella zoster virus Adjuvanted subunit vaccine offers long-lasting protection The results of ZOSTER-049 – an extension of two Phase III clinical trials – show that the adjuvanted recombinant zoster vaccine (RZV) can provide protection against shingles for a decade…
